Sionna Therapeutics, Inc. Common Stock SION Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Liquidity | ||||||
| Current ratio | 22.6×— | 20.6×— | 25.6×— | —— | —— | |
| Quick ratio | 22.6×— | 20.6×— | 25.6×— | —— | —— | |
| Cash ratio | 6.6×— | 5.1×— | 5.3×— | —— | —— | |
| Leverage | ||||||
| Debt-to-equity | 0×— | 0×— | —— | —— | —— | |
| Debt-to-assets | 0×— | 0×— | 0×— | —— | —— | |
| Per Share | ||||||
| Book value per share | $6.42-51.5% | $7.68+118% | $7.27— | $7,625.84— | $13.23— | |
| Valuation | ||||||
| Market capitalization | $1.8B— | —— | —— | —— | —— | |
| Enterprise value | $1.75B— | —— | —— | —— | —— | |
| Price / book | 6.3×— | —— | —— | —— | —— | |
| Free cash flow yield | -4%— | —— | —— | —— | —— | |
| Earnings yield | -4.7%— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Sionna Therapeutics, Inc. Common Stock's ratios come from?
- Every ratio is computed from Sionna Therapeutics, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.